PeterGottliebMD

Endocrinology • Aurora, CO

Diabetes, Lipid Metabolism

Professor, Pediatrics, University of Colorado School of Medicine

Join to view full profile

Dr. Gottlieb is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gottlieb's full profile

Already have an account?

Office
1775 Aurora Ct
Aurora, CO 80045
Phone(303) 724-2323
Fax(303) 724-6784
Is this information wrong?

Summary

Dr. Peter Gottlieb is an endocrinologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital and Children's Hospital Colorado. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 33 years. He specializes in diabetes and lipid metabolism and is experienced in diabetes mellitus, chronic adrenal insufficiency, and autoimmune disease.

Education & Training

University of MassachusettsFellowship, Endocrinology, Diabetes and Metabolism, 1987 - 1990
University of MassachusettsResidency, Internal Medicine, 1984 - 1987
Rutgers Robert Wood Johnson Medical SchoolClass of 1984

Certifications & Licensure

CO State Medical License 1994 - 2021
MA State Medical License 1986 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Jan 01Resnick, B.,Isaacs, C.,Torok, C.,Smith, C.,Felner, E.,Tsalikian, E.,Gaglia, J.,Terrell, J.K.,Smith, J.,Cabbage, J.,DiMeglio, L.,Pruneda, L.,Rendell, M.,Raviele, N.,Gottlieb, P.,Raskin, P.,Gitelman, S.E.,W...
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Start of enrollment: 2013 Mar 01Moran, A.,Greenbaum, C.,Wilson, D.,Ng, D.,Matheson, D.,Schatz, D.A.,Wherrett, D.,Becker, D.,Greenberg, E.,Skyler, J.S.,Marks, J.,Smith, J.,Riley, K.,Herold, K.,Feldman, L.,Weiner, L.,Eisel, L.,DiMeglio, L...
The Effects of Open Label Alpha-1 Antitrypsin on the Progression of Type 1 Diabetes in Subjects With Detectable C-peptide Start of enrollment: 2010 Oct 01Michels, A.,Gottlieb, P.
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01Bode, B.,Counts, D.,Tsalikian, E.,Weir, G.,Berg, J.,Moore, J.,Herold, K.,Lee, M.,Gottschalk, M.,Sherry, N.A.,Gottlieb, P.,Goland, R.,Willi, S.M.,Hoffman, T.
A Randomized, Blinded, Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type I Diabetes Mellitus Start of enrollment: 2006 Oct 01Gottlieb, P.,Harrison, L.,Quan, J.

Publications & Presentations

PubMed

Advances in Diabetes Treatment - Once-Weekly Insulin.
Peter A. Gottlieb, Aaron W. Michels> ;The New England Journal of Medicine. 2020 Nov 26
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Kevan C. Herold, Jesse Reynolds, James Dziura, David Baidal, Jason L. Gaglia, Stephen E. Gitelman, Peter A. Gottlieb, Jennifer B. Marks, Louis H. Philipson, Rodica Pop...> ;Diabetes, Obesity and Metabolism. 2020 Nov 1
Clinical trial data validate the C-peptide estimate model in type 1 diabetes.
John M. Wentworth, Naiara G Bediaga, Stephen E. Gitelman, Carmela Evans-Molina, Peter A. Gottlieb, Peter G. Colman, Michael J. Haller, Leonard C. Harrison> ;Diabetologia. 2020 Jan 26
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia, Simi Ahmed, Mark S. Anderson, Mark A. Atkinson, Dorothy J. Becker, Polly J. Bingley, Emanuele Bosi, Todd M. Brusko, Linda A. DiMeglio, Carmella Evan...> ;Diabetes Care. 2020 Jan 1
Immunomodulatory activity of humanized anti–IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes
Kevan C. Herold, Samantha L. Bucktrout, Xiao Wang, Bruce W. Bode, Stephen E. Gitelman, Peter A. Gottlieb, Jing Hughes, Tenshang Joh, Janet B. McGill, Jeremy Pettus, Sh...> ;JCI insight. 2019 Dec 19
Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes
Kimber M. Simmons, Alexandra Fouts, Laura Pyle, Pamela Clark, Fran Dong, Liping Yu, Sahar Usmani-Brown, Peter A. Gottlieb, Kevan C. Herold, Andrea K. Steck> ;International Journal of Molecular Sciences. 2019 Aug 8
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, J. Krischer, Peter S. ...> ;The New England Journal of Medicine. 2019 Jun 9
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
Rocky L. Baker, Marynette Rihanek, Anita C. Hohenstein, Maki Nakayama, Aaron W. Michels, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong> ;Diabetes. 2019 Jun 7
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clin...
Michael J. Haller, S. Alice Long, J Lori Blanchfield, Desmond A. Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Susan Geyer, Megan V. Warnock, Jessica L M...> ;Diabetes. 2019 Jun 1
Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.
Gisela M. Vaitaitis, Marynette Rihanek, Aimon K. Alkanani, Dan M. Waid, Peter A. Gottlieb, David H. Wagner> ;The Journal of Clinical Endocrinology and Metabolism. 2019 May 7
Rationally designed small molecules to prevent type 1 diabetes.
David A. Ostrov, Peter A. Gottlieb, Aaron W. Michels> ;Current Opinion in Endocrinology, Diabetes and Obesity. 2019 Apr 1
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
Ana Luisa Perdigoto, Paula Preston-Hurlburt, Pamela Clark, S. Alice Long, Peter S. Linsley, Kristina M. Harris, S. E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, ...> ;Diabetologia. 2019 Apr 1
Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity
Mia J. Smith, B Rhodes Ford, Marynette Rihanek, Brianne M. Coleman, Andrew Getahun, Virginia D. Sarapura, Peter A. Gottlieb, John C. Cambier> ;JCI insight. 2019 Feb 7
Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
Taylor M. Triolo, Alexandra Fouts, Laura Pyle, Liping Yu, Peter A. Gottlieb, Andrea K. Steck> ;Diabetes Care. 2019 Feb 1
Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes.
Robert Z. Harms, Kristina M. Lorenzo-Arteaga, Katie R. Ostlund, Victoria B. Smith, Lynette M. Smith, Peter A. Gottlieb, Nora Sarvetnick> ;Frontiers in Immunology. 2018 Oct 22
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
Federica Vecchio, Nicola Lo Buono, Angela Stabilini, Laura Nigi, Matthew J. Dufort, Susan Geyer, Paola M.V. Rancoita, Federica Cugnata, Alessandra Mandelli, Andrea Val...> ;JCI insight. 2018 Sep 20
Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes
Patrick G. Gavin, Jane A. Mullaney, Dorothy Loo, Kim-Anh Lê Cao, Peter A. Gottlieb, Michelle M. Hill, Danny Zipris, Emma E. Hamilton-Williams> ;Diabetes Care. 2018 Aug 9
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes
Michael J. Haller, Desmond A. Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica L Miller, Mark A. Atkinson, Dorothy J. Becker, David Baidal, Linda A....> ;Diabetes Care. 2018 Jul 13
10 citations
Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.
Carla J. Greenbaum, Cate Speake, Jeffrey P. Krischer, Jane H. Buckner, Peter A. Gottlieb, Desmond A. Schatz, Kevan C. Herold, Mark A. Atkinson> ;Diabetes. 2018 Jul 1
Learning From Past Failures of Oral Insulin Trials
Aaron W. Michels, Peter A. Gottlieb> ;Diabetes. 2018 Jul 1
7 citations
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
David A. Ostrov, Aimon K. Alkanani, Kristen A. McDaniel, Stephanie Case, Erin E. Baschal, Laura Pyle, Samuel L. Ellis, Bernadette Pöllinger, Katherine J. Seidl, Viral ...> ;Journal of Clinical Investigation. 2018 May 1
Loss of B-Cell Anergy in Type 1 Diabetes Is Associated With High-Risk HLA and Non-HLA Disease Susceptibility Alleles
Mia J. Smith, Marynette Rihanek, Clive Wasserfall, Clayton E. Mathews, Mark A. Atkinson, Peter A. Gottlieb, John C. Cambier> ;Diabetes. 2018 Apr 1
Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop
Eddie A. James, Joana R. F. Abreu, John W. McGinty, Jared M. Odegard, Yvonne E. Fillié, Claire N. Hocter, Slobodan Culina, Kristin Ladell, David Price, Aimon K. Alkana...> ;Diabetologia. 2018 Mar 1
Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.
Mia J. Smith, Marynette Rihanek, Brianne M. Coleman, Peter A. Gottlieb, Virginia D. Sarapura, John C. Cambier> ;Journal of Autoimmunity. 2017 Dec 1
Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S. Anderson, Jane H. Buckner, Susan Geyer, Peter A. Gottlieb, Thomas W. H. Kay, Åke Lernmark, Sarah Muller, Alberto Pugliese, Bart O. Roep, Car...> ;Diabetologia. 2017 Sep 26
Join now to see all